Effect of Wearable Health Technology on Patients Treated for Chronic Pain at Geisinger Health System

Completed

Conditions studied: Chronic Pain

In brief

This is a proof of concept study to measure the effect of Wearable Health Technology (WHT), including the Apple Watch, iPhone, Pain App and Provider Dashboards on important clinical outcomes in patients treated for chronic pain. WHT will be tested in a group of chronic pain patients treated at a specialty pain clinic, the Geisinger Multidisciplinary Pain Program (MPP). Primary and secondary outcomes include pain, physical function, depression, pain medicine use, amount of sleep, activity levels, healthcare resource utilization and cost. The WHT will collect self-reported data on pain, pain management therapies, and medication utilization, and passively collected data on subject activity levels and sleep. Additional data will be collected on device utilization by patients and health care professionals.

Key facts

Study ID

NCT03299556

Run by

Purdue Pharma LP

People needed

420

Starts

2017-10-05

Expected to finish

2019-11-30

Last updated by the study team

2024-09-19

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Admission to the MPP
• Completion of the 3-day MPP training
• Ability to understand and complete the informed consent form prior to the initiation of any study procedures
• Adequate motor skills needed to utilize WHT
• Willingness to utilize personal electronic devices and WHT, as expressed and documented during the informed consenting process
• Ability to understand spoken and written English

You may not qualify if…

• Cancer diagnosis, AIDS, end-stage liver disease or end-stage renal disease
• Hospitalization >30 days during the 12 months prior to Index Date
• Nursing home or hospice care during the 12 months prior to Index Date
• Presence of an EHR Diagnosis description "OPT-OUT CENTER RESEARCH" which indicates the subject has opted out of (i.e., does not wish to be included in) any Geisinger retrospective research
• Has a terminated Medicine Use Agreement on their Problem List, indicator for substance abuse/dependence

Where it is running

• Geisinger Health System — Danville, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.